Lee, H.;                     Kim, B.;                     Kim, M.;                     Yoo, S.;                     Lee, J.;                     Hwang, E.;                     Kim, Y.    
        Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin A as a High-Potency Therapeutic against Colistin-Resistant Escherichia coli. Pharmaceutics 2023, 15, 1752.
    https://doi.org/10.3390/pharmaceutics15061752
    AMA Style
    
                                Lee H,                                 Kim B,                                 Kim M,                                 Yoo S,                                 Lee J,                                 Hwang E,                                 Kim Y.        
                Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin A as a High-Potency Therapeutic against Colistin-Resistant Escherichia coli. Pharmaceutics. 2023; 15(6):1752.
        https://doi.org/10.3390/pharmaceutics15061752
    
    Chicago/Turabian Style
    
                                Lee, Hyeju,                                 Byeongkwon Kim,                                 Minju Kim,                                 Seoyeong Yoo,                                 Jinkyeong Lee,                                 Eunha Hwang,                                 and Yangmee Kim.        
                2023. "Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin A as a High-Potency Therapeutic against Colistin-Resistant Escherichia coli" Pharmaceutics 15, no. 6: 1752.
        https://doi.org/10.3390/pharmaceutics15061752
    
    APA Style
    
                                Lee, H.,                                 Kim, B.,                                 Kim, M.,                                 Yoo, S.,                                 Lee, J.,                                 Hwang, E.,                                 & Kim, Y.        
        
        (2023). Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin A as a High-Potency Therapeutic against Colistin-Resistant Escherichia coli. Pharmaceutics, 15(6), 1752.
        https://doi.org/10.3390/pharmaceutics15061752